Last reviewed · How we verify

NCT06238739

Optimal Temperature Control in Body Contouring Procedures

Completed NA Last updated 2 February 2024
What this trial tests

NA trial testing Control - Standard Strategies for hypothermia prevention in Hypothermia in 197 participants. Completed in 30 July 2023.

Timeline
1 June 2022
Primary endpoint
30 July 2023
30 July 2023

Quick facts

Lead sponsorTotal Definer Research Group
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingdouble
Primary purposeprevention
Enrollment197
Start date1 June 2022
Primary completion30 July 2023
Estimated completion30 July 2023
Sites1 location across Colombia

Drugs / interventions tested

Conditions studied

Sponsor

Total Definer Research Group

Who can join

Adults 18 to 60, any sex, with Hypothermia or Postoperative Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this clinical trial is to compare different strategies for normothermia prevention in patients undergoing body contouring and other Aesthetic Plastic Surgery procedures. The main question(s) it aims to answer are: * Do active measures have an impact on preventing hypothermia in patients undergoing cosmetic procedures? * Does an active normothermia prevention protocol have any impact in the clinical setting? Four different protocols will be used for patient peroperative preparation for normothermia.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Hypothermia

Currently open trials in the same condition.

Other Total Definer Research Group trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06238739.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing